23andMe is shutting down its therapeutics development division and plans to seek out buyers to find a new home for its ...

Founder Anne Wojcicki still thinks the startup is savable Should You Prune Hydrangeas In the Fall? The #1 fast food chain in the US isn't McDonald's, according to diners. See the top 23.

Genetic-testing lab 23andMe plans to cut its workforce by 40% and end its therapeutics program in an effort to cut costs, the ...

American businesswoman Anne Wojcicki is the co-founder and CEO of genetic testing company 23andMe. She became a billionaire after the company went public in 2021 but since then, the company’s ...

That request epitomises the fall of a company that transformed its chief executive and founder Anne Wojcicki, ex-wife of Google founder Sergey Brin, into a paper billionaire when it floated three ...

Andre Fernandez, Jim Frankola and Mark Jensen will join the company's CEO Anne Wojcicki on the board. The new board members are Andre Fernandez, the former chief financial officer of WeWork; Jim ...

Anne Wojcicki wanted to run things—alone. It was 2009 and her startup 23andMe was riding high, fueled by a steady stream of venture money, intriguing personal accounts of genome exploration ...

Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her leadership style. “What will be most interesting is writing the story in ...

Reduces workforce by roughly 40%; expects annualized cost savings of more than $35 millionDiscontinues development of therapeutics division and ...

Following the resignation of every independent member of the company’s board of directors, its chief executive, Anne Wojcicki, expressed openness to selling the company and its database of ...

CEO Anne Wojcicki has also previously said she'd consider a potential takeover of the company, which has raised concerns among customers about what would happen to their data in the event of a sale.